Press

For press enquires, please email

press@sanogenetics.com

Places we’ve been featured
places featured
icon pricing

Customised plans and pricing
options aligned to your objectives

A flexible approach to meet your study’s goals

pricing-image

We understand that every research project is unique, and we are dedicated to providing you with the most suitable and cost-effective solutions. 

Whether you're conducting a large-scale clinical trial, a targeted genetic study, or anything in between, our team is here to ensure that you receive the best value for your investment.

True success comes from personalised collaboration, and we begin each project by working closely with our clients to understand their research goals and create a tailored plan that fits your budget and objectives. 

From the press

Sano Genetics raises $11.4 million led by Plural to power precision medicine revolution with seamless trials

Sano Genetics raises $11.4 million led by Plural to power precision medicine revolution with seamless trials

Sano Genetics is the only software platform tailored to running precision medicine clinical trials, leveraging AI to manage all aspects from.
Introducing Light the Way [press release]

Introducing Light the Way [press release]

Families affected by ALS urged to join free program to uncover their genetic risk, contribute to research, and access new therapies Sano Gen.
£330K grant awarded to support and engage patients at risk of MND/ALS

£330K grant awarded to support and engage patients at risk of MND/ALS

£330K grant awarded to support and engage patients at risk of MND/ALS, and track the psychological impact of genetic testing.
Sano Genetics raises $11M in funding to accelerate genetic disease research

Sano Genetics raises $11M in funding to accelerate genetic disease research

Sano raises $11 million in Series A funding round led by MMC Ventures New funding will support the team to grow and further its mission to a.
Sano Genetics accelerates research into Long Covid after raising £2.5M ($3.2M) in seed funding

Sano Genetics accelerates research into Long Covid after raising £2.5M ($3.2M) in seed funding

Sano Genetics supports personalised medicine research by increasing participation in clinical trials and guiding patients through the proces.